Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 19628192)

1.

Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

Bayturan O, Tuzcu EM, Nicholls SJ, Balog C, Lavoie A, Uno K, Crowe TD, Magyar WA, Wolski K, Kapadia S, Nissen SE, Schoenhagen P.

JACC Cardiovasc Interv. 2009 Jul;2(7):672-8. doi: 10.1016/j.jcin.2009.05.007.

2.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators.

JAMA. 2006 Apr 5;295(13):1556-65. Epub 2006 Mar 13.

PMID:
16533939
3.

Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.

Shin ES, Garcia-Garcia HM, Okamura T, Serruys PW.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1643-52. doi: 10.1007/s10554-011-9989-9. Epub 2011 Dec 18.

PMID:
22179944
4.

Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.

Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, De Bruyne B, Farhat N, Niess G, Jankovic I, Lazar D, Xu K, Fahy M, Serruys PW, Stone GW.

JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S62-72. doi: 10.1016/j.jcmg.2012.02.003.

5.

Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.

Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ.

JACC Cardiovasc Interv. 2009 Jul;2(7):679-88. doi: 10.1016/j.jcin.2009.03.015.

6.
7.

Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).

Otagiri K, Tsutsui H, Kumazaki S, Miyashita Y, Aizawa K, Koshikawa M, Kasai H, Izawa A, Tomita T, Koyama J, Ikeda U.

Circ J. 2011;75(3):633-41. Epub 2011 Jan 24.

9.

Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2010 Nov 1;106(9):1241-7. doi: 10.1016/j.amjcard.2010.06.046. Epub 2010 Sep 9.

PMID:
21029819
10.

Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.

Dohi T, Mintz GS, McPherson JA, de Bruyne B, Farhat NZ, Lansky AJ, Mehran R, Weisz G, Xu K, Stone GW, Maehara A.

JACC Cardiovasc Imaging. 2013 Aug;6(8):908-16. doi: 10.1016/j.jcmg.2013.04.008. Epub 2013 Jul 10.

11.

Coronary plaque characterization of nonculprit or nontarget lesions assessed by analysis of in vivo intracoronary ultrasound radio-frequency data.

Liu HL, Zhang J, Ma DX, Luo JP, Yang SL, Han W, Liu Y, Jing LM, Meng RY.

Chin Med J (Engl). 2009 Mar 20;122(6):622-6.

PMID:
19323923
12.

Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses.

Maehara A, Cristea E, Mintz GS, Lansky AJ, Dressler O, Biro S, Templin B, Virmani R, de Bruyne B, Serruys PW, Stone GW.

JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S1-9. doi: 10.1016/j.jcmg.2011.11.019.

14.

Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.

Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T.

JACC Cardiovasc Interv. 2009 Jul;2(7):689-96. doi: 10.1016/j.jcin.2009.04.016.

15.

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M; COSMOS Investigators.

Circ J. 2009 Nov;73(11):2110-7. Epub 2009 Oct 5.

16.

Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, Hwang SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Circ J. 2011;75(2):398-406. Epub 2010 Dec 9.

17.

Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes.

Lee SY, Mintz GS, Kim SY, Hong YJ, Kim SW, Okabe T, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ.

JACC Cardiovasc Interv. 2009 Jan;2(1):65-72. doi: 10.1016/j.jcin.2008.08.022.

18.

Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Shiono Y, Kubo T, Tanaka A, Tanimoto T, Ota S, Ino Y, Aoki H, Ozaki Y, Orii M, Shimamura K, Ishibashi K, Yamano T, Yamaguchi T, Hirata K, Imanishi T, Akasaka T.

JACC Cardiovasc Interv. 2013 Aug;6(8):847-53. doi: 10.1016/j.jcin.2013.01.142. Epub 2013 Jul 17.

19.

Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.

Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T.

J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062.

20.

Coronary artery calcification and changes in atheroma burden in response to established medical therapies.

Nicholls SJ, Tuzcu EM, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Nissen SE.

J Am Coll Cardiol. 2007 Jan 16;49(2):263-70. Epub 2006 Nov 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk